Evoke Pharma Inc (EVOK)
4.33
-0.17
(-3.78%)
USD |
NASDAQ |
Nov 22, 16:00
4.22
-0.11
(-2.54%)
After-Hours: 20:00
Evoke Pharma Cash from Investing (Quarterly)
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2014 | 0.00 |
| September 30, 2014 | |
| June 30, 2014 | |
| March 31, 2014 | 0.00 |
| Date | Value |
|---|---|
| December 31, 2013 | 0.00 |
| September 30, 2013 | 0.00 |
| June 30, 2013 | |
| March 31, 2013 | 0.00 |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (Quarterly) Benchmarks
| Eli Lilly and Co | -4.005B |
| MEI Pharma Inc | 14.70M |
| Revance Therapeutics Inc | 23.29M |
| NovaBay Pharmaceuticals Inc | -0.002M |
| Palatin Technologies Inc | 0.00 |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -0.8187M |
| Cash from Financing (Quarterly) | 2.980M |
| Free Cash Flow | -5.325M |
| Free Cash Flow Per Share (Quarterly) | -0.5848 |
| Free Cash Flow to Equity (Quarterly) | -0.8187M |
| Free Cash Flow Yield | -129.5% |